Register Login

INHIBIKASE THERAPEUTICS, INC. (IKT)

(80% Positive) INHIBIKASE THERAPEUTICS, INC. (IKT) Announces Enrollment Update for Variables Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review

Full text
Register to leave comments
  • News bot April 7, 2026, 12:09 p.m.

    📋 INHIBIKASE THERAPEUTICS, INC. (IKT) - Clinical Trial Update

    Filing Date: 2026-04-07

    Accepted: 2026-04-07 08:09:02

    Event Type: Clinical Trial Update

    Event Details:

    INHIBIKASE THERAPEUTICS, INC. (IKT) Announces Clinical Trial Update INHIBIKASE THERAPEUTICS, INC. (IKT) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: Variables, milestone
    • Diseases/Conditions: a Phase 3 Evaluation of PAH, Inhibikase
    • Clinical Stage: Phase 3, Phase 3 study
    • Collaboration: Measuring Pulmonary Vascular Resistance and Outcome Variables

    🔬 Clinical Development Pipeline (INHIBIKASE THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Imatinib Mesylate DRUG Phase PHASE1 CML ClinicalTrials.gov
    IKT-001 DRUG Phase PHASE3 Pulmonary Arterial Hypertension ClinicalTrials.gov
    Placebo DRUG Phase PHASE3 Pulmonary Arterial Hypertension ClinicalTrials.gov
    TDM-105795 topical vehicle solution DRUG Phase PHASE2 Alopecia, Androgenetic ClinicalTrials.gov
    TDM-105795, 0.02% DRUG Phase PHASE2 Alopecia, Androgenetic ClinicalTrials.gov
    TDM-105795, 0.0025% DRUG Phase PHASE2 Alopecia, Androgenetic ClinicalTrials.gov
    Placecbo DRUG Phase PHASE2 Restless Leg Syndrome ClinicalTrials.gov
    BRC-002 DRUG Phase PHASE2 Restless Leg Syndrome ClinicalTrials.gov
    Vehicle Solution DRUG Phase PHASE2 Plaque Psoriasis ClinicalTrials.gov
    188-0551 Solution DRUG Phase PHASE2 Plaque Psoriasis ClinicalTrials.gov
    Vehicle DRUG Phase PHASE2 Psoriasis ClinicalTrials.gov
    122-0551 DRUG Phase PHASE2 Plaque Psoriasis ClinicalTrials.gov
    Vehicle Lotion DRUG Phase PHASE3 Plaque Psoriasis ClinicalTrials.gov
    000-0551 Lotion DRUG Phase PHASE3 Plaque Psoriasis ClinicalTrials.gov
    IkT-001Pro DRUG Phase PHASE1 CML ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: INHIBIKASE THERAPEUTICS, INC.
    • Ticker Symbol: IKT

Search

News categories